Thu, Mar 5, 2015, 2:02 PM EST - U.S. Markets close in 1 hr 58 mins


% | $
Quotes you view appear here for quick access.

Prana Biotechnology Limited Message Board

  • simonig simonig Apr 24, 2013 12:34 PM Flag

    Eisai and Ed609

    Anyone know about Eisai's trial drug Ed609 for Alzheimers and how it works? See Following:

    This time, GE Healthcare will ally with Eisai, a Japanese pharmaceutical giant. Eisai is revving up a Phase I clinical trial for Ed609, an amyloid inhibitor and hoped-for Alzheimer's treatment. To help select patients for a trial, Eisai will use GE's flutemetamol, a PET imaging agent designed to help diagnose Alzheimer's disease by detecting beta amyloid buildup in the brain.

1.12-0.01(-0.88%)1:58 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.